Stock comparison
Sotera Health
Summit Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
SHC
Sotera Health
Market cap
$4.35B
Sector
Healthcare
SMMT
Summit Therapeutics
Market cap
$13.08B
Sector
Healthcare
Overall winner
Sotera Health SHC
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | SHC | SMMT | Winner |
|---|---|---|---|
| Warren Buffett | 51C | 12F | SHC |
| Benjamin Graham | 78B | 40D | SHC |
| Philip Fisher | 47D | 38D | SHC |
| Peter Lynch | 30F | 64C | SMMT |
| Joel Greenblatt | 24F | 0F | SHC |
| Charlie Munger | 54C | 15F | SHC |
| Terry Smith | 52C | 15F | SHC |
Side-by-side metrics
| Metric | SHC | SMMT |
|---|---|---|
| Market cap | $4.35B | $13.08B |
| P/E (TTM) | 36.9x | - |
| EV/EBIT | 16.1x | - |
| ROIC (TTM) | 7.96% | -2.48% |
| Gross margin | 55.01% | 0.0% |
| Net margin | 9.91% | 0.0% |
| Revenue CAGR 5y | 5.72% | - |
| EPS CAGR 5y | -9.92% | 39.68% |
| Debt / Equity | 3.6x | 0.0x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
SHC leads on
- ROIC (TTM)7.96%vs -2.48%+103%
- Gross margin55.01%vs 0.0%+100%
- Net margin9.91%vs 0.0%+100%
SMMT leads on
- EV/EBIT-vs 16.1x+174%
- P/E (TTM)-vs 36.9x+134%
- EPS CAGR 5y39.68%vs -9.92%+125%
- Debt / Equity0.0xvs 3.6x+99%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.